Kyverna Therapeutics, Inc. SEC filings KYTX
Kyverna Therapeutics, Inc. has 187 filings in SEC EDGAR's recent list, going back to Oct 5, 2023. Its latest annual report, Form ARS, was filed on Apr 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 24, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Apr 2, 2026 | — |
| S-8 | Employee stock plan registration | Mar 26, 2026 | — |
| S-3 | Shelf registration | Mar 26, 2026 | — |
| 424B5 | Prospectus supplement | Dec 18, 2025 | — |
| FWP | Free writing prospectus | Dec 17, 2025 | — |
| 424B5 | Prospectus supplement | Dec 15, 2025 | — |
| 424B5 | Prospectus supplement | Apr 15, 2025 | — |
| S-8 | Employee stock plan registration | Mar 27, 2025 | — |
| S-3 | Shelf registration | Mar 27, 2025 | — |
| S-8 | Employee stock plan registration | Nov 26, 2024 | — |
| S-8 | Employee stock plan registration | Feb 8, 2024 | — |
| 424B4 | Prospectus | Feb 8, 2024 | — |
| S-1/A | Amended registration statement | Feb 6, 2024 | — |
| S-1/A | Amended registration statement | Feb 1, 2024 | — |
| S-1 | Registration statement | Jan 16, 2024 | — |
Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- KYTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Emeryville, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1994702
- Former names
- Kyverna Therapeutics, Inc. (until Oct 19, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.